@article{48674f1dbf174dacb488076226a06537,
title = "Disconnect for Tezepelumab on exacerbations, symptoms and quality of life in type 2 low asthma",
author = "Brian Lipworth and Rory Chan",
note = "Funding Information: Supported by a grant from AstraZeneca for clinical studies with tezepelumab as part of the WAYPINT trial in patients with chronic rhinosinusitis with nasal polyposis and in the BISA trial with benralizumab in patients with severe eosinophlic asthma, as well as payment for giving talks (B.L.). Also, supported by Sanofi/Regeneron for a clinical study (DISA) in severe asthma with dupilumab and also the SINUS 24 study with dupilumab in patients with chronic rhinosinusitis and nasal polyposis, as well as payment for talks (B.L.).",
year = "2023",
month = jul,
day = "15",
doi = "10.1164/rccm.202304-0746LE",
language = "English",
volume = "208",
pages = "211",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",
}